Vireo Growth (VREOF) Inventory (2020 - 2026)
Vireo Growth (VREOF) posted Inventory of $76.1 million for Q1 2026, up 26.83% sequentially from $60.0 million in Q4 2025, and up 226.0% YoY from $23.3 million in Q1 2025.
Vireo Growth (VREOF) Inventory (2020 - 2026) Analysis & Trends
Vireo Growth has reported Inventory for 7 years, with the latest figure at $76.1 million in Q1 2026.
- Quarterly Inventory rose 226.0% year-over-year to $76.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $76.1 million (up 226.0% YoY) and the FY2025 annual result came in at $60.0 million, up 176.93% from the prior year.
- Inventory rose to $76.1 million in Q1 2026 per VREOF's latest filing, from $60.0 million in the prior quarter.
- Over five years, Inventory peaked at $76.1 million in Q1 2026 and troughed at $18.3 million in Q1 2022.
- A 5-year average of $30.2 million and a median of $20.1 million in 2024 frame the typical range for Inventory.
- The sharpest annual moves came in 2024 and 2026: Inventory slipped 11.42% in 2024, then soared 226.0% in 2026.
- Over 5 years, Inventory stood at $20.5 million in 2022, then retreated by 5.96% to $19.3 million in 2023, then rose by 12.34% to $21.7 million in 2024, then surged by 176.93% to $60.0 million in 2025, then grew by 26.83% to $76.1 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $76.1 million, $60.0 million, and $53.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 816.00 Mn |
| 10 | Vireo Growth | 491.44 Mn | 349.14 Mn | 95.30 Mn | 149.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.10 Mn |
| Dec 31, 2025 | 60.00 Mn |
| Sep 30, 2025 | 53.90 Mn |
| Jun 30, 2025 | 63.03 Mn |
| Mar 31, 2025 | 23.34 Mn |
| Dec 31, 2024 | 21.67 Mn |
| Sep 30, 2024 | 19.85 Mn |
| Jun 30, 2024 | 20.09 Mn |
| Mar 31, 2024 | 19.36 Mn |
| Dec 31, 2023 | 19.29 Mn |
| Sep 30, 2023 | 19.06 Mn |
| Jun 30, 2023 | 19.78 Mn |
| Mar 31, 2023 | 21.85 Mn |
| Dec 31, 2022 | 20.51 Mn |
| Sep 30, 2022 | 19.11 Mn |
| Jun 30, 2022 | 18.61 Mn |
| Mar 31, 2022 | 18.26 Mn |
| Dec 31, 2021 | 20.42 Mn |
| Sep 30, 2021 | 20.14 Mn |
| Jun 30, 2021 | 16.73 Mn |